Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 5 studies | 21% ± 1% | |
| basal cell | 5 studies | 26% ± 7% | |
| epithelial cell | 4 studies | 35% ± 4% | |
| goblet cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of SH2D3A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 99% | 1339.69 | 571 / 578 | 99% | 17.18 | 1138 / 1155 |
| thymus | 100% | 1583.04 | 653 / 653 | 97% | 13.92 | 584 / 605 |
| pancreas | 100% | 1189.59 | 328 / 328 | 96% | 26.48 | 171 / 178 |
| prostate | 93% | 2167.09 | 229 / 245 | 96% | 11.38 | 484 / 502 |
| kidney | 100% | 1516.26 | 89 / 89 | 78% | 6.30 | 700 / 901 |
| stomach | 76% | 878.67 | 274 / 359 | 99% | 17.46 | 282 / 286 |
| bladder | 67% | 1035.00 | 14 / 21 | 96% | 23.25 | 486 / 504 |
| breast | 63% | 980.58 | 288 / 459 | 97% | 10.75 | 1083 / 1118 |
| intestine | 54% | 948.57 | 518 / 966 | 99% | 21.71 | 521 / 527 |
| esophagus | 43% | 1140.13 | 623 / 1445 | 99% | 18.10 | 182 / 183 |
| uterus | 24% | 135.22 | 40 / 170 | 86% | 20.18 | 397 / 459 |
| ovary | 12% | 35.05 | 22 / 180 | 97% | 12.70 | 417 / 430 |
| spleen | 100% | 663.55 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.87 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 30.01 | 1 / 1 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 6.92 | 27 / 29 |
| skin | 72% | 1959.46 | 1306 / 1809 | 9% | 0.57 | 44 / 472 |
| peripheral blood | 74% | 589.22 | 687 / 929 | 0% | 0 | 0 / 0 |
| liver | 17% | 64.43 | 38 / 226 | 23% | 5.23 | 93 / 406 |
| adipose | 10% | 34.16 | 116 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 6% | 23.44 | 86 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 3.09 | 2 / 258 | 4% | 0.29 | 10 / 230 |
| muscle | 3% | 10.50 | 27 / 803 | 0% | 0 | 0 / 0 |
| heart | 1% | 3.27 | 7 / 861 | 0% | 0 | 0 / 0 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0.02 | 2 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
| GO_0007254 | Biological process | JNK cascade |
| GO_0007264 | Biological process | small GTPase-mediated signal transduction |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0001784 | Molecular function | phosphotyrosine residue binding |
| Gene name | SH2D3A |
| Protein name | SH2 domain-containing protein 3A (Novel SH2-containing protein 1) SH2 domain containing 3A |
| Synonyms | UNQ175/PRO201 NSP1 |
| Description | FUNCTION: May play a role in JNK activation. |
| Accessions | ENST00000437152.7 [Q9BRG2-2] M0QZQ6 ENST00000245908.11 [Q9BRG2-1] Q9BRG2 ENST00000597687.1 |